Recently, the 28th Congress of Chinese Ophthalmological Society was held in Wuhan, Hubei Province. The Congress gathered 15,000 Chinese and foreign experts and delegates to contribute wisdom to the modernization and high-quality development of Chinese ophthalmology.
In order to promote the vigorous development of the cause of ophthalmology and accelerate the company’s goal to realize the integration of Chinese and Western ophthalmology products, joint development and win the battle for the future, Grand Pharma, with its three member companies, Xi’an Beilin Pharmaceutical, Hubei Grand EBE Pharmaceutical and Tianjin Jingming New Technology, was invited to participate in this conference, Tianjin Jingming New Technology were invited to participate in this meeting. Grand Pharma actively supports the high quality development of ophthalmology in China, which greatly enhances the visibility of the company in the industry.
